Qnomx
Basel
About Qnomx
Our vision is to make expert clinical reasoning scalable in precision oncology by integrating multimodal patient data - genomics, clinical context, imaging, and trial evidence - into one explainable reasoning layer. Qnomx will translate complex inputs into concise, auditable interpretations that support consistent therapy decisions across labs and oncology care settings.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.2M
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2025)
- Website: qnomx.ai
- Phone: [email protected]
Industries & Categories
Bioinformatics, Generative AI, Genetics, Health Diagnostics, Oncology
Social Profiles
Canonical: https://fsome.com/organization/qnomx-61314 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.